This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1JH Gurwitz , TS Field , J Avorn et al.Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87–94.
2JT Hanlon , KE Schmader , CM Ruby , M Weinberger . Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9.
4DW Habicht , MD Witham , MET McMurdo . The under-representation of older people in clinical trials: Barriers and potential solutions. J Nutr Health Aging 2008; 12: 194–96.
9PA Routledge , MS O'Mahony , KW Woodhouse . Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57: 121–26.
10M Franceschi , C Scarcelli , V Niro et al.Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31: 545–56.
11I Mukhopadhyay , F Lally , P Crome . Appropriate prescribing in older people. Rev Clin Gerontol 2007; 17: 139–51.
12PA Parish . Drug prescribing – the concern of all. R Soc Health J 1973; 93: 213–17.
13M Somel , P Khaitovich , S Bahn , S Paabo , M Lachmann . Gene-expression becomes heterogenous with age. Curr Biol 2006; 16: R359–60.
14EA Nelson , D Dannefer . Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist 1992; 32: 17–23.
16SHD Jackson , AA Mangoni , GM Batty . Optimization of drug prescribing. Br J Clin Pharmacol 2004; 57: 231–36.
17The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatric Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2012; 60: 616–31.
18N Barber . What constitutes good prescribing? BMJ 1995; 310: 923–25.
19EAG Joosten , L DeFuentes-Merillas , GH de Weert , T Sensky , CPF van der Staak , CAJ de Jong . Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008; 77: 219–26.
21JH Lewis , ML Kilgore , DP Goldman et al.Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21: 1383–89.
22LF Hutchins , JM Unger , JJ Crowley , CA Coltman , KS Albain . Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061–67.
23JG Ford , MW Howerton , GY Lai et al.Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 2008; 112: 228–42.
24MW Rich , MS Bosner , MK Chung , J Shen , JP McKenzie . Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med 1992; 92: 7–13.
25PY Lee , KP Alexander , BG Hammill , SK Pasquali , ED Peterson . Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–13.
26FA Masoudi , EP Havranek , P Wolfe et al.Most hospitalized older persons do not meet the enrolment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250–57.
28BD Smith , GL Smith , A Hurria , GN Hortobagyi , TA Buchholz . Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758–65.
29JM Unger , CA Coltman , JJ Crowley et al.Impact of the year 2000 Medicare policy change on older patient enrolment to cancer clinical trials. J Clin Oncol 2006; 24: 141–44.
30The IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352–63.
31A Cherubini , S Del Signore , J Ouslander , T Semla , JP Michel . Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010; 58: 1791–96.
34S Thomson , P Crome . Appropriate prescribing in older people. Rev Clin Gerontol 2002; 12: 213–20.
35T Kairuz , L Bye , R Birdsall et al.Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging 2008; 25: 153–62.
36E Burns , CA Austin , NDS Bax . Elderly patients’ understanding of their drug therapy: the effect of cognitive function. Age Ageing 1990; 19: 236–40.
37J Nunney , DK Raynor , P Knapp , SJ Closs . How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids? Drugs Aging 2011; 28: 403–14.
40MH Chin , LC Wang , L Jin et al.Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6: 1232–41.
41CM Lindley , MP Tully , V Paramsothy , RC Tallis . Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300.
42MH Beers , JG Ouslander , SF Fingold et al.Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–89.
43MH Beers , JG Ouslander , I Rollinger , DB Reuben , J Brooks , JC Beck . Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825–32.
44D Opondo , S Eslami , S Visscher , SE de Rooij , R Verheij et al.Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS ONE 2012; 7: e43617. doi:10.1371/journal.pone.0043617
45MR Goulding . Inappropriate medication prescribing for elderly ambulatory-care patients. Arch Intern Med 2004; 164: 305–12.
46AE Stuck , MH Beers , A Steiner , HU Aronow , LZ Rubenstein , JC Beck . Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195–200.
47C Zhan , J Sangl , AS Bierman et al.Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 2823–29.
48MS Giron , HX Wang , C Bernsten , M Thorslund , B Winblad , J Fastbom . The appropriateness of drug use in an older non-demented and demented population. J Am Geriatr Soc 2001; 49: 277–83.
49P Gallagher , D O'Mahony . STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008; 37: 673–79.
50CM Boyd , J Darer , C Boult , LP Frier , L Boult , AW Wu . Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716–24.
51A Kennerfalk , A Ruigomez , MA Wallander , L Wilhelmsen , S Johansson . Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797–803.
52C Naughton , K Bennett , J Feely . Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 2006; 35: 633–36.
53D Garfinkel , D Mangin . Feasibility study of a systematic approach for discontinuation of multiple medications in older patients. Arch Intern Med 2010; 170: 1648–54.
54PA Rochon , JH Gurwitz . Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–99.
56V Rollason , N Vogt . Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817–32.
57RK Schwartz , SB Soumerai , J Avorn . Physician motivations for non-scientific drug prescribing. Soc Sci Med 1989; 28: 577–82.
58A Zarba , CL Storr , FA Wagner . Carrying habits into old age: prescription drug use without medical advice by older American adults. J Am Geriatr Soc 2005; 53: 170–71.
59SW Lai , KF Liao , CC Liao , CH Muo , CS Liu , FC Sung . Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 2010; 89: 295–99.
60ER Hajjar , AC Cafiero , JT Hanlon . Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345–51.
61PJ Barry , P Gallagher , C Ryan , D O'Mahony . START (Screening Tool to Alert doctors to Right Treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632–38.
63SB Soumerai , TJ McLaughlin , D Spiegelman , E Hertzmark , G Thibault , L Goldman . Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997: 277: 115–21.
64MH Chin , JC Wang , JX Zhang , RM Lang . Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. J Gen Intern Med 1997; 12: 563–66.
66G Mendelson , WS Aronow . Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1998; 46: 751–52.
67A Cherubini , A Corsonello , F Lattanzio . Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29: 463–75.
68MAJ Kuijpers , RJ van Marum , ACG Egberts , PAF Jansen . Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130–33.
70MH Beers . Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531–36.
71DM Fick , JW Cooper , WE Wade , JL Waller , JR Maclean , MH Beers . Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24.
72P Gallagher , C Ryan , S Byrne , J Kennedy , D O'Mahony . STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83.
73H Hamilton , P Gallagher , C Ryan , S Byrne , D O'Mahony . Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013–19.
77JT Hanlon , KE Schmader , GP Samsa et al.A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51.
78NS Wenger , PG Shekelle . Assessing care of vulnerable elders: ACOVE Project Overview. Ann Intern Med 2001; 135: 642–46.
79MP Tully , JA Cantrill . The validity of explicit indicators of prescribing appropriateness. Int J Qual Health Care 2006; 18: 87–94.
80G Onder , F Landi , R Liperoti , D Fialova , G Gambassi , R Bernabei . Impact of appropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61: 453–59.
81ML Laroche , JP Charmes , Y Nouaille , N Picard , L Merle . Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177–86.
82DS Budnitz , N Shehab , SR Kegler , CL Richards . Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755–65.
83A Spinewine , C Swine , S Dhillon et al.Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007; 55: 658–65.
84ML Laroche , JP Charmes , L Merle . Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725–31.
85EL Knight , J Avorn . Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001; 135: 703–10.
86NS Wenger , CP Roth , P Shekelle , ACOVE Investigators. Introduction to the assessing care of vulnerable elders – 3 quality indicator measurement set. J Am Geriatr Soc 2007; 55 (suppl 2): S247–52.
88R Kassam , LG Martin , KB Farris . Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003; 37: 40–46.
89JA Cantrill , B Sibbald , S Buetow . Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility and reliability. Qual Saf Health Care 1998; 7: 130–35.
92SA Buetow , B Sibbald , JA Cantrill , S Halliwell . Appropriateness in health care: application to prescribing. Soc Sci Med 1997; 45: 261–71.
93CA Oborne , GM Batty , V Maskrey , CG Swift , SH Jackson . Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91–97.
94RL Grant , GM Batty , R Aggarwal et al.National sentinel clinical audit of evidence-based prescribing for older people: methodology and development. J Eval Clin Pract 2002; 8: 189–98.
95D O'Mahony , MN O'Connor . Pharmacotherapy at the end-of-life. Age Ageing 2011; 40: 419–22.
96AR Maddison , J Fisher , G Johnston . Preventive medication use among persons with limited life expectancy. Prog Palliat Care 2011; 19: 15–21.
97JE Hardy , SN Hilmer . Deprescribing in the last year of life. J Pharm Pract Res 2011; 41: 146–51.
98DC Currow , JP Stevenson , AP Abernethy , J Plummer , TM Shelby-James . Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590–95.
99C Faull , K Windridge , E Ockleford , M Hudson . Anticipatory prescribing in terminal care at home: what challenges do community health professionals encounter? BMJ Support Palliat Care 2013; 3: 91–97.
100MA Steinman , CS Landefeld , GE Rosenthal , D Berthenthal , S Sen , PJ Kaboli . Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516–23.
101WH Shrank , JM Polinski , J Avorn . Quality indicators for medication – use in vulnerable elders. J Am Geriatr Soc 2007; 55: S373–82.
104DS Budnitz , MC Lovegrove , N Shehab , CL Richards . Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002–12.
105J Ansell , J Hirsh , E Hylek , A Jacobsen , M Crowther , G Palareti . Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008;133 (suppl 6): 160–98S.
108M Crotty , J Halbert , D Rowett et al.An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612–17.
109JYF Wu , WYS Leung , S Chang et al.Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006; 333: 522–28.
110M Monane , DM Matthias , BA Nagle , MA Kelly . Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA 1998; 280: 1249–52.
111JM Teich , PR Merchia , JL Schmitz , GJ Kuperman , CD Spurr , DW Bates . Effects of computerized physician order entry on prescribing practices. Arch Intern Med 2000; 160: 2741–47.
112DW Bates , LL Leape , DJ Cullen et al.Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–16.
113DW Bates . Using information technology to reduce rates of medication errors in hospitals. BMJ 2000; 320: 788–91.
114GJ Kuperman , A Bobb , TH Payne et al.Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14: 29–40.
116E Charani , Y Kyratsis , W Lawson et al.An analysis of the development and implementation of a smartphone application for the delivery of antimicrobial prescribing policy: lessons learnt. J Antimicrob Chemother 2013; 68: 960–67.
117L Dayer , S Heldenbrand , P Anderson , PO Gubbins , BC Martin . Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc 2013; 53: 172–81.
118F Haffey , RRW Brady , S Maxwell . A comparison of the reliability of smartphone apps for opioid conversion. Drug Safety 2013; 36: 111–17.
119AL Hume , BJ Quilliam , R Goldman , C Eaton , KL Lapane . Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. BMJ Qual Saf 2011; 20: 875–84.
121H Merten , M Zegers , MC de Bruijne , C Wagner . Scale, nature, preventability and causes of adverse events in hospitalised older patients. Age Ageing 2013; 42: 87–93.